Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
ANIX Anixa Biosciences, Inc. daily Stock Chart
ANIX [NASD]
Anixa Biosciences, Inc.
Healthcare | Diagnostics & Research | USA
statements
Index- P/E- EPS (ttm)-0.46 Insider Own5.40% Shs Outstand23.52M Perf Week-6.02%
Market Cap58.50M Forward P/E- EPS next Y-0.53 Insider Trans14.66% Shs Float21.69M Perf Month23.79%
Income-9.50M PEG- EPS next Q-0.13 Inst Own5.90% Short Float6.08% Perf Quarter44.85%
Sales0.00M P/S- EPS this Y25.90% Inst Trans- Short Ratio3.13 Perf Half Y1.44%
Book/sh0.25 P/B11.24 EPS next Y2.00% ROA-150.00% Target Price- Perf Year-32.61%
Cash/sh0.26 P/C10.64 EPS next 5Y- ROE-173.90% 52W Range1.33 - 5.45 Perf YTD-14.33%
Dividend- P/FCF- EPS past 5Y11.80% ROI-228.70% 52W High-48.44% Beta1.65
Dividend %- Quick Ratio5.30 Sales past 5Y-41.60% Gross Margin- 52W Low111.28% ATR0.33
Employees7 Current Ratio5.30 Sales Q/Q- Oper. Margin- RSI (14)53.87 Volatility9.86% 12.49%
OptionableNo Debt/Eq0.00 EPS Q/Q3.40% Profit Margin- Rel Volume0.69 Prev Close3.01
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume421.30K Price2.81
Recom2.00 SMA203.20% SMA5020.97% SMA200-3.67% Volume289,843 Change-6.64%
Jul-10-20 07:25AM  
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Benzinga +13.01%
07:00AM  
Anixa Biosciences' CAR-T Cancer Therapy Receives Intention to Grant Notice from the European Patent Office
PR Newswire
Jul-06-20 09:00AM  
Anixa and OntoChem Announce Completion of Initial Screening Program and Identification of Additional Covid-19 Compounds
PR Newswire
Jul-02-20 05:00PM  
Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic and Vaccine Pipeline
PR Newswire +6.71%
Jun-01-20 08:30AM  
Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays
PR Newswire
May-04-20 06:45AM  
Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate
PR Newswire +7.61%
Apr-28-20 06:32AM  
Have Insiders Been Buying Anixa Biosciences, Inc. (NASDAQ:ANIX) Shares?
Simply Wall St.
Apr-23-20 07:00AM  
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek Liquid Biopsy Technology
PR Newswire
Apr-21-20 06:00PM  
San Jose bioscience company launches research into Covid-19 treatment
American City Business Journals
Apr-20-20 06:30AM  
Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics
PR Newswire
Mar-23-20 06:28AM  
Here's Why We're Watching Anixa Biosciences's (NASDAQ:ANIX) Cash Burn Situation
Simply Wall St. -11.35%
Mar-02-20 07:00AM  
Anixa Biosciences Announces Presentation at AI and Big Data in Cancer Conference
PR Newswire
Feb-12-20 07:00AM  
Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program
PR Newswire
Feb-11-20 07:16AM  
Top Ranked Momentum Stocks to Buy for February 11th
Zacks
Jan-06-20 07:00AM  
Anixa Biosciences Announces Presentation at AACR Liquid Biopsies Conference
PR Newswire
Jan-02-20 05:25AM  
Investors Who Bought Anixa Biosciences (NASDAQ:ANIX) Shares Three Years Ago Are Now Down 38%
Simply Wall St. -8.54%
Dec-23-19 07:00AM  
Anixa Biosciences to Present at Biotech Showcase 2020
PR Newswire
Dec-16-19 06:45AM  
Anixa Biosciences Announces Commercial Launch of Cchek Prostate Cancer Confirmatory Test
PR Newswire
Dec-13-19 05:45PM  
Anixa Biosciences to Host Conference Call to Discuss Plans for 2020
PR Newswire -15.10%
06:45AM  
Anixa Biosciences Provides Update on CAR-T Program
PR Newswire
Dec-02-19 07:00AM  
Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium
PR Newswire
Nov-26-19 07:00AM  
Anixa Biosciences Announces Genesis Research to Join Cchek Prostate Cancer Study
PR Newswire +7.29%
Nov-22-19 07:00AM  
Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek Prostate Cancer Study
PR Newswire
Nov-20-19 07:00AM  
Anixa Biosciences Announces Collaboration with Idaho Urologic Institute on Cchek Prostate Cancer Study
PR Newswire
Nov-07-19 07:00AM  
Anixa Biosciences Announces Presentation at Cell Symposia: Hallmarks of Cancer
PR Newswire
Nov-05-19 07:00AM  
Anixa Biosciences Announces Patent Issued for its Breast Cancer Vaccine
PR Newswire
Nov-03-19 07:38AM  
What Kind Of Shareholders Own Anixa Biosciences, Inc. (NASDAQ:ANIX)?
Simply Wall St.
Oct-28-19 07:00AM  
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
PR Newswire
Oct-25-19 07:00AM  
Anixa Biosciences Announces Collaboration with Urology San Antonio on Cchek Prostate Cancer Study
PR Newswire
Oct-22-19 07:00AM  
Anixa Biosciences Announces Abstract Accepted for Presentation at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2019)
PR Newswire
Oct-15-19 07:00AM  
Anixa Biosciences Appoints Dr. Thomas Schlumpberger as Executive Vice President of Diagnostics to Head Liquid Biopsy Development and Commercialization Efforts
PR Newswire +5.11%
Oct-10-19 07:00AM  
Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board
PR Newswire
Sep-23-19 07:00AM  
Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek Prostate Cancer Study
PR Newswire
Sep-19-19 07:53AM  
Should You Worry About Anixa Biosciences, Inc.'s (NASDAQ:ANIX) Cash Runway?
Simply Wall St.
07:00AM  
Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek Prostate Cancer Study
PR Newswire
Sep-16-19 07:00AM  
Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree
PR Newswire
Aug-26-19 07:00AM  
Anixa Biosciences to Present at Two Upcoming Investor Conferences
PR Newswire
Jul-29-19 07:00AM  
Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek Prostate Cancer Study
PR Newswire
Jul-24-19 07:00AM  
Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology
PR Newswire +5.25%
Jul-23-19 01:22PM  
Have Insiders Been Buying Anixa Biosciences, Inc. (NASDAQ:ANIX) Shares?
Simply Wall St.
Jul-22-19 07:00AM  
Anixa Biosciences Announces U.S. Department of Veterans Affairs VA Maryland Health Care System Joins Cchek Prostate Cancer Study
PR Newswire
Jul-17-19 12:25PM  
Anixa Bioscience's Deal With Cleveland Clinic Sends Shares Higher
Benzinga +13.08%
07:00AM  
Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology
PR Newswire
Jul-16-19 07:00AM  
Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived Suppressor Cells
PR Newswire
May-29-19 07:00AM  
Anixa Biosciences to Present at the CYTO 2019 - 34th Congress of the International Society for Advancement of Cytometry
PR Newswire
May-24-19 02:56PM  
What Type Of Shareholder Owns Anixa Biosciences, Inc.'s (NASDAQ:ANIX)?
Simply Wall St.
May-21-19 07:00AM  
Anixa Biosciences to Present at the Sachs Associates 5th Annual Immuno-Oncology BD&L and Investment Forum
PR Newswire
May-13-19 07:00AM  
Anixa Biosciences Announces Completion of Cchek Analytical Verification at CLIA Laboratory
PR Newswire
May-02-19 07:00AM  
Anixa Biosciences to Present at B. Riley FBR Institutional Investor Conference
PR Newswire
Apr-17-19 07:00AM  
US Patent & Trademark Office Issues Patent on Anixa Biosciences CAR-T Cancer Treatment Technology
PR Newswire
Apr-11-19 07:00AM  
Anixa Biosciences Extends and Expands its Collaboration with New Jersey Urology
PR Newswire
Apr-03-19 02:00PM  
Anixa Biosciences Presents Cchek Prostate Cancer Detection Data at AACR Annual Meeting
PR Newswire
Mar-27-19 07:00AM  
Anixa Biosciences CEO to Present at the New York Academy of Sciences Symposium on Cancer Immunotherapy
PR Newswire
Mar-25-19 07:00AM  
U.S. Department of Veterans Affairs and McGuire Research Institute Join Anixa Biosciences Cchek Prostate Cancer Study
PR Newswire
Mar-14-19 07:00AM  
Anixa Biosciences Announces Notice of Allowance for Additional Cancer Detection Technology Patent
PR Newswire
Mar-13-19 12:48PM  
Does Anixa Biosciences, Inc. (NASDAQ:ANIX) Have A Volatile Share Price?
Simply Wall St.
Mar-04-19 07:00AM  
Anixa Biosciences to Present Cchek Technology and Data at the Molecular Medicine Tri-Conference
PR Newswire
Feb-28-19 07:00AM  
Anixa Biosciences to Present Latest Prostate Cancer Data at the 2019 American Association for Cancer Research (AACR) Annual Meeting
PR Newswire
Feb-25-19 07:00AM  
Anixa Biosciences Announces Partnership with ResearchDx for Launch of Cchek Prostate Cancer Confirmation Test
PR Newswire
Feb-21-19 07:00AM  
Anixa Biosciences Extends Collaborative Research Agreement with The Wistar Institute and Leading Myeloid-derived Suppressor Cell Researcher Dmitry I. Gabrilovich, M.D., Ph.D.
PR Newswire
Feb-13-19 07:00AM  
Anixa Biosciences to Present at Moffitt Cancer Center's Business of Biotech Conference
PR Newswire
Feb-05-19 11:17AM  
What Are Analysts Saying About Anixa Biosciences, Inc.s (NASDAQ:ANIX) Earnings Trajectory?
Simply Wall St.
Jan-25-19 07:00AM  
Anixa Biosciences Conference Call Recording Available on Company Website
PR Newswire -9.92%
Jan-24-19 07:00AM  
Anixa Biosciences CAR-T Cancer Therapy Patent Receives Notice of Allowance
PR Newswire +9.29%
Jan-16-19 07:30AM  
Anixa Biosciences to Hold Conference Call to Discuss Outlook for 2019
PR Newswire +8.31%
Dec-26-18 11:05AM  
Should You Take Comfort From Insider Transactions At Anixa Biosciences, Inc. (NASDAQ:ANIX)?
Simply Wall St. +5.25%
Dec-19-18 07:00AM  
Anixa Biosciences Announces Completion of Pre-Sub Meeting with FDA for its Cchek Cancer Diagnostic Test
PR Newswire
Dec-03-18 07:00AM  
Anixa Biosciences Presents Positive Data on its Liquid Biopsy for Early Detection of Breast Cancer at AACR Conference
PR Newswire
Nov-15-18 07:00AM  
Anixa Biosciences To Present Cchek Breast Cancer Data at AACR Special Conference on Tumor Immunology and Immunotherapy
PR Newswire +5.83%
Nov-12-18 07:00AM  
Anixa Biosciences Presents Positive Data from its Artificial Intelligence Powered Liquid Biopsy for Prostate Cancer at SITC Conference
PR Newswire
Oct-29-18 07:00AM  
Anixa Biosciences to Present at SITC Annual Meeting
PR Newswire
Oct-24-18 07:00AM  
Anixa Biosciences Announces Scheduling of Pre-Sub Meeting with FDA for its Cchek Cancer Diagnostic Test
PR Newswire
Oct-22-18 07:00AM  
Moffitt Cancer Center and Anixa Biosciences Announce Completion of Pre-IND Meeting with FDA for CAR-T Therapy
PR Newswire -28.24%
Oct-17-18 07:00AM  
Anixa Biosciences Releases Data Presented at AACR Artificial Intelligence Conference
PR Newswire
Oct-16-18 10:59AM  
Are Anixa Biosciences Incs (NASDAQ:ANIX) Interest Costs Too High?
Simply Wall St.
Oct-15-18 07:00AM  
Anixa Biosciences Files Pre-Submission and Requests Meeting with FDA Regarding Cchek Artificial Intelligence based Cancer Detection Technology
PR Newswire +14.26%
Oct-11-18 07:00AM  
Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board
PR Newswire -7.11%
Oct-05-18 07:00AM  
Anixa Biosciences to Present at Artificial Intelligence Conference
PR Newswire
Anixa Biosciences, Inc., a biotechnology company, develops diagnostics and therapeutics to diagnose, treat, and prevent cancer. The company is developing the Cchek platform, a series of non-invasive blood tests for the early detection of cancer, which is based on the body's immune response to the presence of a malignancy. It is also developing a vaccine against triple negative breast cancer; and chimeric endocrine receptor T-cell technology focused on treating ovarian cancer. Anixa Biosciences, Inc. has a collaboration with Urology San Antonio, P.A. and Idaho Urologic Institute, PA for the development of Cchek, a liquid biopsy technology; and with OntoChem GmbH to develop novel Covid-19 therapeutics. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was founded in 1982 and is based in San Jose, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Titterton Lewis H jrDirectorJun 16Buy2.2724,50055,615980,326Jun 17 10:30 AM
Titterton Lewis H jrDirectorJun 15Buy2.2731,08370,558955,826Jun 16 11:43 AM
KUMAR AMITChief Executive OfficerJun 12Buy2.0320,00040,600234,000Jun 12 10:48 AM
Titterton Lewis H jrDirectorMar 13Buy2.125,79912,294924,743Mar 17 03:46 PM
Baskies Arnold MDirectorMar 12Buy1.8410,00018,40041,000Mar 12 01:38 PM
KUMAR AMITChief Executive OfficerMar 12Buy1.8220,00036,400214,000Mar 12 10:26 AM
Baskies Arnold MDirectorMar 06Buy2.7110,00027,10031,000Mar 10 02:54 PM
Baskies Arnold MDirectorJan 17Buy3.5310,00035,30021,000Jan 21 11:45 AM
Titterton Lewis H jrDirectorJan 15Buy3.325,00016,600918,944Jan 16 11:22 AM
Titterton Lewis H jrDirectorJan 14Buy3.227,40023,828913,944Jan 15 10:57 AM
KUMAR AMITChief Executive OfficerJan 14Buy2.9920,00059,800194,000Jan 14 10:47 AM
open in yahoo | open in reuters | open in google